STA opening new transition metal catalysis center at API site

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Sky_Blue)
(Image: iStock/Sky_Blue)

Related tags: Catalysis, Molecule

The new Changzhou, China-based site adds transition metal catalyst-screening technology to STA’s small molecule process development and manufacturing platform.

STA Pharmaceutical, a WuXi AppTec company, will launch the new center at its integrated API process R&D and manufacturing site in Changzhou, China.

According to the company, the facility will allow it to perform rapid screening of metal catalysts, ligands, bases, acids, chemical resolving reagents, and amide formation coupling reagents.

Additionally, the technology uses a parallel interactive testing approach, the company said.

STA is currently training a team of scientists specialized in the technology who will move to the Changzhou site when the center becomes fully operational in November.

Related news

Show more

Related products

show more

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Related suppliers

Follow us

Products

View more

Webinars